In the US, CDC data shows that over 40% of adults are obese and 9.7% are severely obese.1 Obesity, a chronic disease, increases the risk of...
A large study analyzing data from over 60 million patients find no evidence that GLP-1 receptor agonists increase the risk of suicide Type 2 diabetes patientschallenges...
Antiobesity drugs are associated with reduced alcohol use, likely due to their effects on craving and reward systems, and behavioral strategies also play a role. study:...
Researchers from Massachusetts General Brigham and colleagues found that the use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023, and surgery...
New research published in scientific journal addiction People with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar drugs to treat diabetes or...
A Cleveland Clinic study identified key factors that may affect long-term weight loss in obese patients prescribed injectable semaglutide or liraglutide for the treatment of type...
Recent Comments